Roles of P2 receptors in glial cells: focus on astrocytes
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Central nervous system glial cells release and respond to nucleotides under both physiological and pathological conditions, suggesting that these molecules play key roles in both normal brain function and in repair after damage. In particular, ATP released from astrocytes activates P2 receptors on astrocytes and other brain cells, allowing a form of homotypic and heterotypic signalling, which also involves microglia, neurons and oligodendrocytes. Multiple P2X and P2Y receptors are expressed by both astrocytes and microglia; however, these receptors are differentially recruited by nucleotides, depending upon specific pathophysiological conditions, and also mediate the long-term trophic changes of these cells during inflammatory gliosis. In astrocytes, P2-receptor-induced gliosis occurs via activation of the extracellular-regulated kinases (ERK) and protein kinase B/Akt pathways and involves induction of inflammatory and anti-inflammatory genes, cyclins, adhesion and antiapoptotic molecules. While astrocytic P2Y1 and P2Y2,4 are primarily involved in short-term calcium-dependent signalling, multiple P2 receptor subtypes seem to cooperate to astrocytic long-term changes. Conversely, in microglia, exposure to inflammatory and immunological stimuli results in differential functional changes of distinct P2 receptors, suggesting highly specific roles in acquisition of the activated phenotype. We believe that nucleotide-induced activation of astrocytes and microglia may originally start as a defence mechanism to protect neurons from cytotoxic and ischaemic insults; dysregulation of this process in chronic inflammatory diseases eventually results in neuronal cell damage and loss. On this basis, full elucidation of the specific roles of P2 receptors in these cells may help exploit the beneficial neuroprotective features of activated glia while attenuating their harmful properties and thus provide the basis for novel neuroprotective strategies that specifically target the purinergic system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“Among various substances, including growth factors, cytokines, chemoattractants and neurotransmitters [11], extracellular ATP has been indicated as a key messenger in microglial activation.”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“[34] showed that the fine termini of microglial processes are highly dynamic.”
BackgroundStevens (2002) · doi:10.1016/s0896-6273(02)01067-x · Cited by 543
Pro‐regenerative properties of cytokine‐activated astrocytes
Liberto, C. M., Albrecht, P. J., Herx, L. M., Yong, V. W., & Levison, S. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02420.x · Cited by 464
A neuron–glia signalling network in the active brain
Bezzi, P., & Volterra, A. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00223-3 · Cited by 446
Boucsein, C., Zacharias, R., Färber, K., Pavlovic, S., Hanisch, U., & Kettenmann, H. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02663.x · Cited by 203 · cited 1×
“All these parameters were reduced in the presence of purinergic ligands, suggesting that purinergic receptor activation may attenuate indicators of microglial activation [18].”
BackgroundMarchetti, B., & Abbracchio, M. P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.08.007 · Cited by 175 · cited 5×
“, stroke), as well as chronic neurodegenerative and demyelinating disorders (Alzheimer_s, Parkinson_s, Huntington_s diseases and multiple sclerosis; for reviews, see [27, 41].”
BackgroundInfluentialSelf-citation
Cited by
Verkhratsky, A., & Nedergaard, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2016 · Cited by 1,678
“Cortical astrocytes in culture express mRNA for P2Y1,2,4,6,12,13 and UDP-glucose P2Y14 receptor (4, 141, 435, 541), whereas spinal cord astrocytes predominantly express transcripts for P2Y1,2 receptors (495).”
Purinergic signalling in the nervous system: an overview
Abbracchio, M. P., Burnstock, G., Verkhratsky, A., & Zimmermann, H. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.10.001 · Cited by 860
Self-citationAustin, P. J., & Moalem-Taylor, G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.013 · Cited by 607
Buffo, A., Rolando, C., & Ceruti, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.014 · Cited by 321
Self-citationVerkhratsky, A., Parpura, V., Vardjan, N., & Zorec, R. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-9913-8_3 · Cited by 312
Metadata
- Authors
- Abbracchio, M. P., & Ceruti, S.
- Venue
- Purinergic Signalling
- Published
- 2006-06-20
- Volume
- 2
- Issue
- 4
- Pages
- 595-604
- ISSN
- 1573-9538 (ISSN-L)
- 1573-9546
- OpenAlex
- W2005629604
- Cited by
- 116
- References
- 7
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Roles of P2 receptors in glial cells: focus on astrocytes. https://app.cochat.ai/papers/10.1007/s11302-006-9016-0
- The paper
- Abbracchio, M. P., & Ceruti, S. (2006). Roles of P2 receptors in glial cells: focus on astrocytes. Purinergic Signalling. https://doi.org/10.1007/s11302-006-9016-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.